Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 6

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 3
Chunk 6
---
 $1.00 per share. Between May and July, 2023, EUDA raised an aggregate of $790,000 from the sale of 790,000 shares of restricted
ordinary shares at $1.00 per share. Between May and June 2023, as a result of a number of transactions between EUDA and each of its then
CEO and two current shareholders who held promissory notes or claims against EUDA, EUDA was able to settle in full its debt obligations
in the aggregate amount of $1,617,606 by issuing a total of 1,345,739 ordinary shares to these three creditors, two of whom are related
parties to EUDA. In March 2024, the Company paid its two then executive officers and an executive director an aggregate of 295,361 ordinary
shares in lieu of cash compensation to conserve cash. In March 2024, the Company and James Tan entered into a settlement agreement pursuant
to which the Company issued to James Tan convertible note in the aggregate amount of $24,004 in full satisfaction of a then outstanding
loan and extended the maturity date of the then outstanding loan to March 14, 2025. In March 2024, the Company and an affiliate of James
Tan entered into a settlement agreement pursuant to which the Company issued James Tan’s affiliate a convertible note in the aggregate
amount of $911,373 in full satisfaction of certain outstanding loans and service payments. From March 14, 2024 to the date of this report,
8i Enterprises Pte Ltd (“8iEPL”), an affiliate of James Tan has extended a loan in the aggregate amount of $1,021,000 to EUDA.
Alfred Lim has also provided an additional loan of $90,000 to EUDA. (see “ Item 7B. Related Party Transactions”). During the
fiscal year 2024 to the date of this report, an unaffiliated third party also extended a loan of $511,000 to EUDA. There are no assurances
that related parties or unaffiliated third parties will accept shares of the Company as payment for any of their future loans or services
to the Company.

   5  

If
EUDA raises additional funds through further issuances of equity or convertible debt securities, existing shareholders could suffer significant
dilution, and any new equity securities issued could have rights, preferences and privileges superior or similar to those of holders
of ordinary shares. EUDA could also face